2024 annual financial data
Radiopharm Theranostics 2024 Operating margin
Radiopharm Theranostics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -12,238.44%.
Operating income was -36,620,852 AUD and net income was -47,949,119 AUD.
Operating cash flow was -22,975,935 AUD.
Get free Radiopharm Theranostics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 299,228 AUD
- Operating income
- -36,620,852 AUD
- Net income
- -47,949,119 AUD
- Operating cash flow
- -22,975,935 AUD